228 results
Page 4 of 12
424B5
2g43xt2 1l2m9
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
xuqr7yrq0694g0u gc97
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
424B2
52hkad7es4 5kbp
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-10.1
1as4cnz
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
d23pa81xlsbpnt8ujw
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
ubpa4b 44
17 Jun 20
Submission of Matters to a Vote of Security Holders
4:37pm
424B3
6noqdzwfnzsigh26vqs
8 Jun 20
Prospectus supplement
4:48pm
8-K
EX-4.1
r52x4
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
044oxp1hbf51q3
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
noxrgb w1ha62lds45
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-4.1
0zqtjx17v gm70a0b7
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-4.2
4y958utu6kzd3fec1ce
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm